MyRing 0,120 mg/0,015 mg pro 24 Stunden vaginales Wirkstofffreisetzungssystem
Recall
|
Medicines
|
28/12/2021
The marketing authorisation holder informed its supplied doctors on December 23, 2021 that deviations in the stability tests had been detected in the mentioned batch, which could shorten the shelf life and that no further supply to patients should therefore take place.
| Name of the medicinal product | MyRing 0,120 mg/0,015 mg pro 24 Stunden vaginales Wirkstofffreisetzungssystem |
|---|---|
| Marketing authorisation number(s) | 139315 |
| CIP code | 4974058 |
| Marketing authorisation holder | Gynial GmbH |
| Batch number(s) | 20BAA01701 (doctor's samples) |
| Expiry date | 05/30/2023 |
| BASG reference number | INS-640.001-3721 |
Further inquiry note
Page last modified:
28/12/2021